Markers for Detecting Breast Cancer Cells in Blood
Author Information
Author(s): EM Eltahir, DS Mallinson, GD Birnie, C Hagan, WD George, AD Purushotham
Primary Institution: University Department of Surgery, Western Infirmary, Glasgow
Hypothesis
The study investigates certain genes for their suitability as molecular markers for the detection of breast carcinoma cells using RT-PCR.
Conclusion
The study found that MUC1 and CD44 are non-specific for epithelial cells, and CK19, while specific, has limited sensitivity for detecting breast cancer cells.
Supporting Evidence
- MUC1 and CD44 showed variable expression in normal blood, making them unsuitable as specific markers.
- CK19 was not detected in normal blood but had limited sensitivity in detecting tumor cells.
- Background expression of MUC1 was found in 21 of 23 healthy volunteers.
Takeaway
The researchers looked for markers in blood that could show if someone has breast cancer, but found that the markers they tested weren't good enough.
Methodology
RNA was extracted from MCF-7 breast carcinoma cells and peripheral blood leucocytes, and screened for specific mRNA using RT-PCR.
Limitations
The markers tested showed background expression in healthy individuals, raising doubts about their specificity.
Participant Demographics
Healthy female volunteers aged between 18 and 48 years.
Want to read the original?
Access the complete publication on the publisher's website